GGrantIndex
← Leaderboards

Seyoum Ayehunie

Mattek Corporation

$12,970,385
Attributed
$12,970,385
Total exposure
18
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY200620
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$12,970,385 · 18

By mechanism

R44$7,138,812 · 7
U01$3,362,326 · 1
R43$2,028,895 · 9
R21$440,352 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “In Vitro

Research focus

In VitroCellsTissuesIn VivoCytokineAnimalsScreening ProcedureTissue ModelBaseAnimal ModelResponseHuman TissueReproducibilityCostStructureLaboratoriesCharacteristicsEpitheliumEpithelialEconomicsExposure ToVaginaSafetyIn Vitro Assay

Grant awards (34)

Organotypic Culture Models (OCM) developed from experimental animals for Chemical Toxicity Screening.$252,129
R43 · FY2020 · ES · contact PI
Novel Approach for Characterizing Exposure and Response to Engineered Nanomaterials in the Gut$225,000
R43 · FY2019 · ES · contact PI
Organotypic Rat Tissue Models for Translational Toxicity Assessments$223,936
R43 · FY2019 · ES · contact PI
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$172,979
R44 · FY2018 · GM · contact PI
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$507,987
R44 · FY2017 · GM · contact PI
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$648,815
R44 · FY2016 · GM · contact PI
Use of a CB2 Ligand to prevent HIV-1 Infection and Transmission$221,953
R21 · FY2014 · AI · contact PI
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies$218,331
R43 · FY2014 · GM · contact PI
Use of a CB2 Ligand to prevent HIV-1 Infection and Transmission$218,399
R21 · FY2013 · AI · contact PI
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors$189,035
R44 · FY2013 · ES · contact PI
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors$460,766
R44 · FY2012 · ES · contact PI
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors$327,839
R44 · FY2011 · ES · contact PI
Validation of a Human In Vitro Vaginal Irritation Test$197,217
R44 · FY2011 · HD · contact PI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$619,724
U01 · FY2010 · AI · contact PI
Validation of a Human In Vitro Vaginal Irritation Test$491,867
R44 · FY2010 · HD · contact PI
In Vitro Tissue Model of Psoriasis$436,471
R44 · FY2010 · AR · contact PI
In Vitro Human Tissue Model for Intravaginal Drug Delivery$267,914
R43 · FY2010 · GM · contact PI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$937,758
U01 · FY2009 · AI · contact PI
Validation of a Human In Vitro Vaginal Irritation Test$516,667
R44 · FY2009 · HD · contact PI
In Vitro Tissue Model of Psoriasis$434,712
R44 · FY2009 · AR · contact PI
In Vitro Assay for Chemical Allergens$213,701
R44 · FY2009 · CA · contact PI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$601,624
U01 · FY2008 · AI · contact PI
In Vitro Assay for Chemical Allergens$438,697
R44 · FY2008 · CA · contact PI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$596,569
U01 · FY2007 · AI · contact PI
In Vitro Assay for Chemical Allergens$475,043
R44 · FY2007 · CA · contact PI
Validation of a Human In Vitro Vaginal Irritation Test$212,292
R43 · FY2007 · HD · contact PI
Validation of Organotypic Vaginal Tissue Based Assay for Endocrine Disruptors$211,817
R43 · FY2007 · ES · contact PI
Vaginal/cervical tissue models: endocrine effects and susceptibility to infection$606,651
U01 · FY2006 · AI · contact PI
In Vitro Tissue Model of Psoriasis$210,982
R43 · FY2006 · AR · contact PI
In Vitro Assay For Chemical Allergens$206,494
R43 · FY2004 · CA
Reconstruction of skin model containing Langerhans cells$374,609
R44 · FY2003 · AR
Reconstruction of skin model containing Langerhans cells$456,320
R44 · FY2002 · AR
Immortized Human Langerhans Cells$368,501
R44 · FY2002 · AR
Immortized Human Langerhans Cells$427,586
R44 · FY2001 · AR